Obstetric and Gynecologic Imaging

What Imaging Should You Order After an Inconclusive Ultrasound for Abnormal Uterine Bleeding?

·
What Imaging Should You Order After an Inconclusive Ultrasound for Abnormal Uterine Bleeding?

A 42-year-old G2P2 presents with persistent heavy menstrual bleeding. Her initial transvaginal ultrasound revealed a thickened, heterogeneous endometrium, but the sonographer noted that the endometrial-myometrial junction was poorly defined and a focal lesion could not be definitively excluded. You are now faced with the decision of how to proceed. The initial study was suggestive but not diagnostic, and you need to clarify the underlying cause to guide management, whether it be medical therapy, hysteroscopy, or another intervention. This article provides a detailed clinical workflow for this exact scenario: selecting follow-up imaging for abnormal uterine bleeding (AUB) when the initial ultrasound is inconclusive. According to the American College of Radiology (ACR) Appropriateness Criteria, US sonohysterography is Usually appropriate as the next diagnostic step.

Who Fits This Clinical Scenario?

This guidance applies to post-menarchal patients, both pre- and post-menopausal, who have presented with abnormal uterine bleeding and have already undergone an initial imaging study—typically a transabdominal and/or transvaginal ultrasound—that was inconclusive. An “inconclusive” result can mean several things:

  • The endometrium appears diffusely thickened without a clear focal lesion.
  • A potential focal lesion (like a polyp or submucosal fibroid) is suspected but not clearly characterized.
  • Technical limitations, such as uterine position (e.g., retroversion), co-existing myomas, or patient body habitus, prevented adequate visualization of the endometrial cavity.
  • The endometrial-myometrial junction is indistinct, raising suspicion for adenomyosis but without definitive features.

This workflow is distinct from other clinical situations. It does not apply to patients presenting for their initial imaging workup for AUB, which has its own set of recommendations. It also does not apply to patients who have a well-characterized finding on a prior ultrasound and are undergoing routine surveillance. Finally, this guidance is for the diagnostic workup in a stable patient; it does not address the management of acute, severe uterine hemorrhage in an unstable patient, which requires a different clinical pathway.

What Diagnoses Are You Working Up in This Scenario?

When an initial ultrasound is inconclusive, the goal of follow-up imaging is to differentiate between several key pathologies within the endometrium and myometrium. The differential diagnosis remains broad but is focused on structural causes that the first study failed to characterize.

Endometrial Polyps: These are a very common cause of AUB, particularly intermenstrual bleeding. On a standard ultrasound, a polyp can be difficult to distinguish from diffuse endometrial thickening or a small fibroid. Follow-up imaging aims to clearly delineate the polyp’s stalk and borders, confirming its intracavitary nature.

Submucosal Leiomyomas (Fibroids): While many fibroids are visible on standard ultrasound, their precise relationship to the endometrial cavity is critical for surgical planning. An inconclusive initial study may have failed to determine the percentage of the fibroid that is intracavitary (e.g., FIGO type 0, 1, or 2). This distinction has major implications for whether a hysteroscopic resection is feasible.

Adenomyosis: This condition, where endometrial tissue grows into the myometrium, can cause heavy, painful bleeding. Its sonographic features can be subtle, such as an indistinct endometrial-myometrial border or myometrial heterogeneity, which are often reported as inconclusive findings. Further imaging seeks to confirm these suggestive features or rule out other causes.

Endometrial Hyperplasia or Carcinoma: In at-risk patients (e.g., post-menopausal bleeding, obesity, anovulatory cycles), a thickened or heterogeneous endometrium on an inconclusive ultrasound raises concern for malignancy. Follow-up imaging is crucial to identify any focal, suspicious areas that may warrant targeted biopsy over a blind sampling.

Why Is US Sonohysterography the Recommended Study for This Presentation?

When the initial ultrasound fails to provide a clear diagnosis, the primary challenge is often the inability to distinguish the two layers of the endometrium from each other or from a focal lesion nestled within the cavity. US sonohysterography directly addresses this problem.

The procedure involves instilling sterile saline into the endometrial cavity via a thin catheter while performing a transvaginal ultrasound. This distends the cavity, separating the anterior and posterior walls and creating an anechoic (black) fluid background. Against this background, intracavitary pathology like polyps and submucosal fibroids becomes sharply defined. This technique provides excellent spatial resolution and is highly sensitive for detecting focal endometrial lesions. For these reasons, the ACR rates US sonohysterography as Usually appropriate.

Another highly rated option is MRI of the pelvis without and with IV contrast, also rated Usually appropriate. MRI offers superior soft tissue contrast and is particularly valuable for evaluating the extent of myometrial invasion in suspected cancer, characterizing complex adnexal masses, and definitively diagnosing adenomyosis. It is often the problem-solving tool of choice when sonohysterography is also inconclusive or when a global assessment of the entire pelvis is required.

Why are other studies rated lower? A repeat standard US pelvis transvaginal is rated May be appropriate (Disagreement) because it is unlikely to yield new information if the same technical limitations are present. While valuable, its utility is diminished if it has already proven inconclusive. Similarly, CT of the pelvis is Usually not appropriate for this indication. CT provides poor soft tissue contrast of the uterine layers and exposes the patient to ionizing radiation (1-10 mSv for a pelvic CT) without offering a diagnostic advantage over ultrasound or MRI for this specific clinical question.

What’s Next After US Sonohysterography? Downstream Workflow

The results of the follow-up study will guide the next steps in management, which typically involve a decision between medical therapy, procedural intervention, or further tissue sampling.

  • If the study is positive for a focal lesion (polyp or submucosal fibroid): The patient can be referred to a gynecologist for consideration of hysteroscopic resection. The detailed information from the sonohysterogram or MRI on the lesion’s size, location, and vascularity is critical for pre-operative planning.
  • If the study is negative and the endometrium appears thin and normal: If the patient is pre-menopausal, this result may provide reassurance and shift the focus toward hormonal or other non-structural causes of AUB. Medical management (e.g., hormonal IUD, oral contraceptives) may be the most appropriate next step. In a post-menopausal patient with a truly thin endometrium, the risk of significant pathology is very low.
  • If the study is positive for features of adenomyosis: The diagnosis can be made with a higher degree of confidence, and management can be tailored accordingly. This often involves medical therapies aimed at controlling symptoms, such as hormonal suppression.
  • If the study remains indeterminate or is suspicious for malignancy: If sonohysterography shows a focal, thickened, or irregular area, the next step is typically an endometrial biopsy or hysteroscopy with dilation and curettage (D&C) to obtain a tissue diagnosis. MRI may also be used at this stage to assess for myometrial invasion if cancer is highly suspected.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for an inconclusive ultrasound requires careful consideration to avoid common missteps. Here are a few pitfalls specific to this scenario:

  • Timing the Sonohysterogram Incorrectly: In pre-menopausal women, the study should be performed in the early proliferative phase of the menstrual cycle (typically days 4-10) when the endometrium is at its thinnest, maximizing diagnostic accuracy.
  • Ignoring Patient Contraindications: Sonohysterography is contraindicated in pregnancy and in the presence of active pelvic inflammatory disease. Ensure these are ruled out before ordering.
  • Accepting a Suboptimal Study: If sonohysterography cannot be completed due to cervical stenosis or patient intolerance, or if the results remain equivocal, do not stop the workup. This is a key point to escalate to the next appropriate study, often an MRI.
  • Over-relying on a Blind Biopsy: After an inconclusive ultrasound, proceeding directly to a blind endometrial biopsy may miss focal pathology like a polyp or small cancer. Image-guided evaluation should precede or guide tissue sampling.

If you encounter a complex case with multiple co-existing pathologies (e.g., large fibroids and suspected endometrial thickening), or if imaging findings are discordant with the clinical picture, a consultation with a radiologist specializing in gynecologic imaging or a gynecologic oncologist is warranted.

Related ACR Topics and Tools

This article focuses on a single, specific clinical scenario. For a comprehensive overview of imaging for all presentations of abnormal uterine bleeding, please see our parent guide. For additional resources to help you select the right study and understand the details, explore the tools below.

Frequently Asked Questions

Why not just repeat the transvaginal ultrasound instead of ordering a sonohysterogram?

While a repeat transvaginal ultrasound is rated as *May be appropriate (Disagreement)* by the ACR, it is often unhelpful if the same factors that made the first study inconclusive (e.g., uterine position, co-existing fibroids) are still present. Sonohysterography is designed to overcome these limitations by using saline to distend the uterine cavity, providing a much clearer view of intracavitary structures that a standard ultrasound cannot resolve.

When should I choose MRI over sonohysterography as the next step?

MRI is also rated *Usually appropriate* and is an excellent choice. It is preferred when there is a high suspicion of adenomyosis, a need to evaluate large or numerous fibroids, or a concern for invasive endometrial cancer. It’s also the best problem-solving tool if sonohysterography is technically difficult or contraindicated. The choice can depend on local expertise, cost, and the specific clinical question you are trying to answer.

Is sonohysterography safe in a patient with a history of pelvic inflammatory disease (PID)?

The procedure is contraindicated in patients with *active* PID due to the risk of spreading the infection. In a patient with a remote history of PID who is currently asymptomatic and has no signs of infection on examination, the procedure can generally be performed safely. Some institutions may consider antibiotic prophylaxis in high-risk patients, though this is not universally standard.

What if the patient is post-menopausal and the initial ultrasound showed a thickened endometrium?

This is a critical scenario. While sonohysterography is still an excellent next step to look for a focal cause like a polyp, the primary goal is to rule out endometrial hyperplasia or carcinoma. If sonohysterography confirms a focal lesion, it can guide a targeted biopsy. If it shows diffuse, uniform thickening, an endometrial biopsy is mandatory. In post-menopausal bleeding, any endometrial thickness greater than 4-5 mm on a standard ultrasound warrants further investigation.

Can I order a sonohysterogram if my patient is actively bleeding?

Heavy active bleeding can make the procedure technically challenging, as blood clots within the cavity can mimic pathology and obscure visualization. It is best to schedule the study for after the heavy bleeding has subsided, ideally in the early proliferative phase (days 4-10) of the cycle for pre-menopausal patients. If bleeding is persistent and evaluation is urgent, the procedure can still be attempted, but the interpreting radiologist should be aware of the limitation.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026